Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q2 2021 Results Conference Call August 9, 2021 4:30 PM ET Company Participants Donald Notman - Chief Financial Officer Antony Mattessich - President and Chief Executive Officer Dr. Michael Goldstein - President-Ophthalmology and Chief Medical Officer Scott Corning - Senior Vice President, Commercial Chris White - Senior Vice President, Business and Corporate Development Conference Call Participants Jon Wolleben - JMP Securities Joe Catanzaro - Piper Sandler Georgi Yord ...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ET Company Participants Donald Notman – Chief Financial Officer Antony Mattessich – President and Chief Executive Officer Michael Goldstein – President-Ophthalmology and Chief Medical Officer Conference Call Participants Joe Catanzaro – Piper Sandler Jonathan Wollenben – JMP Securities Georgi Yordanov – Cowen and Company Ed Chung – Jefferies Anita Dushyanth – Berenberg Boobalan Pachaiyappan – H.C. Wainwright Operator ...

(NASDAQ: OCUL) TRANSFORMING DRUG DELIVERY LEVERAGING A NOVEL TECHNOLOGY PLATFORM ANTONY MATTESSICH, CHIEF EXECUTIVE OFFICER March 2021 FORWARD LOOKING STATEMENTS Any statements in this presentation about future expectations, plans, and prospects for the Company, including the commercialization of DEXTENZA®, ReSure® Sealant, or any of the Company's product candidates; the commercial launch of, and effectiveness of reimbursement codes for, DEXTENZA; the conduct of post-approval studies of DEXTENZA; the develo ...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2020 Earnings Conference Call March 11, 2021 4:30 PM ET Company Participants Antony Mattessich - Chief Executive Officer Michael Goldstein - Chief Medical Officer Patricia Kitchen - Chief Operating Officer Donald Notman - Chief Financial Officer Conference Call Participants Dane Leone - RJF David Steinberg - Jefferies Joe Catanzaro - Piper Sandler Jon Wolleben - JMP Securities Georgi Yordanov - Cowen & Company Anita Dushyanth - Berenberg Capital Market Yi Chen - H.C ...

Start Time: 16:30 January 1, 0000 5:12 PM ET Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q3 2020 Earnings Conference Call November 05, 2020, 16:30 PM ET Company Participants Antony Mattessich - President and CEO Michael Goldstein - CMO Patricia Kitchen - COO Donald Notman - CFO Conference Call Participants Dane Leone - Raymond James Joseph Catanzaro - Piper Sandler Jonathan Wolleben - JMP Securities Edward Chung - Jefferies Yi Chen - H.C. Wainwright Operator Good afternoon, ladies and gentlemen. Thank you for st ...

(N A S DA Q : O C UL ) TRANSFORMING DRUG DELIVERY LEVERAGING A NOVEL TECHNOLOGY PLATFORM ANTONY MATTESSICH, CHIEF EXECUTIVE OFFICER MICHAEL GOLDSTEIN, MD, CHIEF MEDICAL OFFICER September 2020 FORWARD LOOKING STATEMENTS Any statements in this presentation about future expectations, plans, and prospects for the Company, including the commercialization of DEXTENZA®, ReSure® Sealant, or any of the Company's product candidates; the commercial launch of, and effectiveness of reimbursement codes for, DEXTENZA; the ...

(NASDAQ: OCUL) TRANSFORMING DRUG DELIVERY LEVERAGING A NOVEL TECHNOLOGY PLATFORM ANTONY MATTESSICH, CHIEF EXECUTIVE OFFICER September 2020 FORWARD LOOKING STATEMENTS Any statements in this presentation about future expectations, plans, and prospects for the Company, including the commercialization of DEXTENZA®, ReSure® Sealant, or any of the Company's product candidates; the commercial launch of, and effectiveness of reimbursement codes for, DEXTENZA; the development and regulatory status of the Company's p ...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q2 2020 Earnings Conference Call August 7, 2020 8:30 AM ET Company Participants Donald Notman - CFO Antony Mattessich - President, CEO & Director Michael Goldstein - Chief Medical Officer Conference Call Participants Joseph Catanzaro - Piper Sandler & Co. Yi Chen - H.C. Wainwright & Co. Dane Leone - Raymond James & Associates Jonathan Wolleben - JMP Securities Operator Good Morning, ladies and gentlemen. Thank you for standing by, and welcome to the Ocular Therapeutix ...

Ocular Therapeutix (NASDAQ:OCUL) Q1 2020 Results Conference Call May 8, 2020 8:30 AM ET Company Participants Donald Notman - CFO Antony Mattessich - President and CEO Dr. Michael Goldstein - Chief Medical Officer Conference Call Participants Joe Catanzaro - Piper Sandler Stacy Ku - Cowen & Co. Jonathan Wolleben - JMP Securities Boobalan Pachaiyappan - H.C. Wainwright Operator Ladies and gentlemen, thank you for standing by and welcome to the First Quarter 2020 Ocular Therapeutix Earnings Conference Call. At ...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2019 Earnings Conference Call March 12, 2020 4:30 PM ET Company Participants Donald Notman - Chief Financial Officer Antony Mattessich - President and Chief Executive Officer Michael Goldstein - Chief Medical Officer Scott Corning - Senior Vice President, Commercial Conference Call Participants Joe Catanzaro - Piper Jaffray Dane Leone - Raymond James & Associates, Inc. Yi Chen - H.C. Wainwright Operator Good afternoon, ladies and gentlemen. Thank you for standing by ...